Contineum Therapeutics Inc (CTNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,426 | -8,417 | 22,720 | 30,489 | 36,740 |
| Depreciation Amortization | 121 | 61 | -3 | -39 | -82 |
| Accounts payable and accrued liabilities | 100 | -70 | N/A | 625 | -31 |
| Other Working Capital | 66 | 275 | -1,024 | 1,766 | 647 |
| Other Operating Activity | 665 | 176 | -2,344 | -2,788 | -1,844 |
| Operating Cash Flow | $-16,474 | $-7,975 | $19,349 | $30,053 | $35,430 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -29,902 | 8,878 | -65,154 | -74,493 | -35,019 |
| PPE Investments | -266 | -147 | -414 | -105 | -83 |
| Investing Cash Flow | $-30,168 | $8,731 | $-65,568 | $-74,598 | $-35,102 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -3,750 | -3,750 | -3,750 |
| Common Stock Issued | 108,346 | 122 | 159 | 109 | 27 |
| Common Stock Repurchased | N/A | N/A | -28 | N/A | N/A |
| Other Financing Activity | 0 | -140 | 59,795 | 60,138 | 49,895 |
| Financing Cash Flow | $108,346 | $-18 | $56,176 | $56,497 | $46,172 |
| Beginning Cash Position | 15,526 | 15,526 | 5,569 | 5,569 | 5,569 |
| End Cash Position | 77,230 | 16,264 | 15,526 | 17,521 | 52,069 |
| Net Cash Flow | $61,704 | $738 | $9,957 | $11,952 | $46,500 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,474 | -7,975 | 19,349 | 30,053 | 35,430 |
| Capital Expenditure | -266 | -147 | -414 | -105 | -83 |
| Free Cash Flow | -16,740 | -8,122 | 18,935 | 29,948 | 35,347 |